| Market Cap | ₹74Cr | 
| ROE | -0.32% | 
| P/E Ratio(TTM) | 82.00 | 
| EPS(TTM) | 0.01 | 
| P/B Ratio | 0.75 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 27.32 | 
| Book Value | 1.09 | 
| Debt to Equity | 0.00 | 
| Face Value | 1 | 
| Parent Organisation | Biogen Pharmachem Industries Limited | 
| Managing Director | NA | 
| BSE Symbol | 531752 | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Tata Capital | NA (0.00%)  | 33.14  | ||
| Aditya Birla Capital | NA (0.00%)  | 26.11  | ||
| HDB Financial Services | NA (0.00%)  | 27.60  | ||
| 360 One Wam | NA (0.00%)  | 39.31  |